Infection Control Market Is Growing Rapidly With STERIS Plc Completing The Acquisition Of Infection Control Service Provider Cantel Medical Corporation
Infection control and management is the field concerned with preventing health-related infections; a more practical rather than the academic subject matter of epidemiology. Infection prevention and control refers to the practice of preventing healthcare-associated infections. Infection control has become an essential part of the infrastructure healthcare with a wide use of antibiotics, antiseptics, antivirals, and antibacterial. The demand for infection control has risen up significantly over the years with growing burden of chronic diseases such as cancer, diabetes, and cardiovascular diseases. As per the World Health Organization (WHO), the global prevalence of diabetes among adults aged 18 years and above increased from 4.7% in 1980 to 8.5% in 2014. According to the same source, in 2018, around 9.6 million deaths were attributed to cancer, of which 2.09 million cases were lung cancer. According to the WHO, around 17.9 million people die of cardiovascular diseases every year. These factors can stimulate growth of the infection control market in the near future.
Although the majority of population
does not realize that, in most hospitals and other healthcare facilities across
the country, outbreaks of deadly diseases occur due to a number of different
reasons. For instance, healthcare workers are under tremendous pressure to work
quickly and efficiently, often without adequate infection control measures in
place. As a result, the results of their efforts can be disastrous.
Furthermore, most hospitals and healthcare facilities are bound by municipal
ordinances that require them to ensure that they maintain a very high level of
cleanliness in their facilities. Such laws and regulations are significantly
strict in developed regions such as North America and thus, the demand for
infection control has increased in the U.S. as well as Canada. The healthcare
infrastructure in the aforementioned countries is robust and fairly advanced as
compared to emerging economies. Furthermore, the hospitals in these countries
are increasingly adopting advanced infection control technologies, to curb the
spread of hospital-acquired diseases.
However, there are major concerns
regarding the safety of reprocessed instruments, which could impede growth of
the infection control market. Besides, there is low awareness regarding
infection control in emerging economies, which remains one of the major
barriers. When infections do occur in healthcare settings, they can quickly
become viral and result in widespread contamination throughout a hospital or
other such environment. Such an infection could then spread among other
personnel, resulting in even more infections. It may be necessary to implement
infection control measures such as a "zero-patient" policy where
there are zero visitors to any patient.
Recently, in January 2021, STERIS plc
acquired Cantel Medical Corporation, a provider of infection control products,
and services.
Comments
Post a Comment